CT, P = 0.04)
The right option depends on your goals, health history, lab work, medications, and provider guidance
Wegovy, a GLP-1 receptor agonist approved for chronic weight management, works by regulating appetite and reducing caloric intake
These are positive developments that will improve access and treatment persistence among patients needing obesity medications, particularly those covered by Medicare, state Medicaid programs in states that will choose to participate, and those who can afford the cash pay option. Meanwhile, he says, recognizing the primary reasons for discontinuation may facilitate more informed discussions between clinicians and their patients, helping to address challenges in long-term persistence with these highly effective medications. Horvath is a freelance writer based in Baltimore, Md
Your healthcare provider can help decide if semaglutide is right for you
This weight loss medication offers a means to assist those on their weight loss journey in achieving more significant results than diet and exercise might allow alone